Bright Ideas - CIN Feasibility Study (NCT04929899)
Improving Chemotherapy-induced Nausea Control Through Bright Ideasยฎ-CIN Training: a Feasibility Study in Children Receiving Oral Chemotherapy
๐ฉบ Plain-English Summary (8th-Grade Level)
In this study investigators will determine the feasibility of a future trial comparing chemotherapy-induced nausea control in children with ALL receiving oral 6-mercaptopurine who do and do not receive problem-solving skill training. This is a novel approach to controlling an important and common treatment-related symptom.
Who can join: Review the eligibility criteria below.
Location: Children's Hospital Los Angeles โ Los Angeles, California
Age range: 4 Years to 18 Years
๐งช Interventions in This Study
- Bright Ideas - CIN Training (BEHAVIORAL)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (4 Sites)
- Children's Hospital Los Angeles โ Los Angeles, California
- Rutgers Cancer Institute โ New Brunswick, New Jersey
- Inova Children's Hospital โ Falls Church, Virginia
- Hospital for Sick Children โ Toronto, Ontario
๐ Contact the Study Coordinator
Phone: (416) 813-7762
Email: lee.dupuis@sickkids.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Acute Lymphoblastic Leukemia (ALL)
- Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT โ Houston, Texas
- TCRฮฑฮฒ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies โ Memphis, Tennessee
- Provision of TCRฮณฮด T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naรฏve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation โ Memphis, Tennessee
Explore by condition: All Acute Lymphoblastic Leukemia (ALL) clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.